Skip to main content
. 2017 Jan 13;8(10):16356–16366. doi: 10.18632/oncotarget.14633

Table 1. The relationship between YAP expression in pancreatic cancer tissue strength and clinical pathological factors.

Negative Weakly positive Moderately positive Strongly positive χ2 P
Gender 0.643 0.577
Male 2 3 5 10
Female 1 2 10 12
Age 0.787 0.565
> 60 1 4 8 13
< 60 2 1 7 9
Smoking 1.452 0.541
Yes 3 4 9 15
No 0 1 6 7
Drinking 1.896 0.224
Yes 1 3 11 16
No 2 2 4 6
BMI 0.000 1.000
BMI > 27 2 4 9 15
BMI < 27 1 1 6 7
Abnormal glucose tolerance 1.773 0.542
Yes 3 3 9 14
No 0 2 6 8
Diabetes 0.952 0.555
Yes 1 2 8 16
No 2 3 7 6
Chronic pancreatitis 0.643 0.577
Yes 2 2 6 10
No 1 3 9 12
Differentiation 5.294 0.048*
Poorly 0 1 11 16
Medium and high 3 4 4 6
T stages 2.143 0.543
T1 2 1 3 9
T2 1 2 6 6
T3 0 2 5 6
T4 0 0 1 1
N stages 0.592 1.000
N0 3 3 13 19
N1 0 2 2 3
Clinical stages 0.153 0.926
I 2 3 11 12
II 1 2 4 8
III 0 0 0 2

*Statistically significant

Elevated YAP activity/expression strongly correlated with tumor histological differentiation in pancreatic cancer tissue (χ2 = 5.294, p = 0.048).